Mutant p53 mediates survival of breast cancer cells

Por Lim, L Y, Vidnovic, N, Ellisen, L W, Leong, C-O
Publicado em 2009

Antitumour 2-(4-aminophenyl)benzothiazoles generate DNA adducts in sensitive tumour cells in vitro and in vivo

Por Leong, C-O, Gaskell, M, Martin, E A, Heydon, R T, Farmer, P B, Bibby, M C, Cooper, P A, Double, J A, Bradshaw, T D, Stevens, M F G
Publicado em 2003

DNA damage and cell cycle arrest induced by 2-(4-amino-3-methylphenyl)-5-fluorobenzothiazole (5F 203, NSC 703786) is attenuated in aryl hydrocarbon receptor deficient MCF-7 cells

Por Trapani, V, Patel, V, Leong, C-O, Ciolino, H P, Yeh, G C, Hose, C, Trepel, J B, Stevens, M F G, Sausville, E A, Loaiza-Pérez, A I
Publicado em 2003

Mutant p53-R273H mediates cancer cell survival and anoikis resistance through AKT-dependent suppression of BCL2-modifying factor (BMF)

Por Tan, B S, Tiong, K H, Choo, H L, Fei-Lei Chung, F, Hii, L-W, Tan, S H, Yap, I KS, Pani, S, Khor, N TW, Wong, S F, Rosli, R, Cheong, S-K, Leong, C-O
Publicado no Cell Death Dis (2015)